Step into the Future of RNAi

Oligonucleotide CMC for Sustainable and Scalable Enzymatic siRNA Manufacturing​

Featured at TIDES USA 

The demand for RNA therapeutics is rapidly growing—bringing with it the challenge of scaling up manufacturing to meet that need. This presentation will explore the impurity profiles, product yields, and reproducibility of various enzymatic processes, and compare these approaches to traditional phosphoramidite chemistry-based oligonucleotide synthesis.

alt_text

Instruction text required